Anchalee Rawangkan, Pattama Wongsirisin, Grissana Pook-In, Achiraya Siriphap, Atchariya Yosboonruang, Anong Kiddee, . . . Ratsada Praphasawat. (2022). Dinactin: A New Antitumor Antibiotic with Cell Cycle Progression and Cancer Stemness Inhibiting Activities in Lung Cancer. MDPI AG.
Chicago Style (17th ed.) CitationAnchalee Rawangkan, et al. Dinactin: A New Antitumor Antibiotic with Cell Cycle Progression and Cancer Stemness Inhibiting Activities in Lung Cancer. MDPI AG, 2022.
MLA (9th ed.) CitationAnchalee Rawangkan, et al. Dinactin: A New Antitumor Antibiotic with Cell Cycle Progression and Cancer Stemness Inhibiting Activities in Lung Cancer. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.